NCRBF(NCRBF)
NCRBF
No analyst ratings available
No analyst price targets available for NCRBF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $39.91B | $41.43B | $42.44B |
| Low | $39.91B | $41.43B | $42.44B |
| High | $39.91B | $41.43B | $42.44B |
| EBITDA Avg | $8.58B | $9.65B | $10.04B |
| Low | $8.58B | $9.65B | $10.04B |
| High | $8.58B | $9.65B | $10.04B |
| EBIT Avg | $5.02B | $6.05B | $6.39B |
| Low | $5.02B | $6.05B | $6.39B |
| High | $5.02B | $6.05B | $6.39B |
| Net Income Avg | $2.99B | $3.60B | $3.81B |
| Low | $2.99B | $3.60B | $3.81B |
| High | $2.99B | $3.60B | $3.81B |
| EPS Avg | $270.03 | $325.88 | $344.53 |
| Low | $270.03 | $325.88 | $344.53 |
| High | $270.03 | $325.88 | $344.53 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 |
|---|---|---|
| Revenue Avg | $9.31B | $11.38B |
| Low | $9.31B | $11.38B |
| High | $9.31B | $11.38B |
| EBITDA Avg | — | — |
| Low | — | — |
| High | — | — |
| EBIT Avg | — | — |
| Low | — | — |
| High | — | — |
| Net Income Avg | — | — |
| Low | — | — |
| High | — | — |
| EPS Avg | — | — |
| Low | — | — |
| High | — | — |
| Analysts (Rev / EPS) | 1 / — | 1 / — |